(Q38078431)

28 August 2017

1 reference

title

Assessing response of therapy for acute and chronic graft-versus-host disease (English)

1 reference

28 August 2017

2

Sergio Giralt

1 reference

28 August 2017

Jenna D Goldberg

1

1 reference

28 August 2017

publication date

1 February 2013

1 reference

Expert Review of Hematology

28 August 2017

published in

1 reference

28 August 2017

volume

6

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

103-107

1 reference

Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease

28 August 2017

cites work

1 reference

Quality of life associated with acute and chronic graft-versus-host disease.

21 January 2018

1 reference

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

21 January 2018

1 reference

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

21 January 2018

1 reference

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes

21 January 2018

1 reference

Have we made progress in the management of chronic graft-vs-host disease?

21 January 2018

1 reference

The best endpoint for acute GVHD treatment trials

21 January 2018

1 reference

Graft-versus-host disease treatment: predictors of survival

21 January 2018

1 reference

Prognostic value of response after upfront therapy for acute GVHD

21 January 2018

1 reference

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

21 January 2018

1 reference

Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study

21 January 2018

1 reference

Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems

21 January 2018

1 reference

Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network

21 January 2018

1 reference

Pitfalls in the design of clinical trials for prevention or treatment of acute graft-versus-host disease

21 January 2018

1 reference

Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD

21 January 2018

1 reference

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria

21 January 2018

1 reference

A biomarker panel for acute graft-versus-host disease

21 January 2018

1 reference

Elafin is a biomarker of graft-versus-host disease of the skin

21 January 2018

1 reference

Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease

21 January 2018

1 reference

Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EHM.12.65

1 reference

28 August 2017

1 reference